PTGX |
Protagonist Therapeutics, Inc |
Sep 11, 2024 |
6 |
-$444K |
4 |
Sep 13, 2024 |
Chief Financial Officer |
PTGX |
Protagonist Therapeutics, Inc |
Apr 18, 2024 |
1 |
-$31K |
4 |
Apr 19, 2024 |
Chief Financial Officer |
PTGX |
Protagonist Therapeutics, Inc |
Feb 29, 2024 |
6 |
-$618K |
4 |
Mar 1, 2024 |
Chief Financial Officer |
PTGX |
Protagonist Therapeutics, Inc |
Jan 16, 2024 |
1 |
-$35.8K |
4 |
Jan 18, 2024 |
Chief Financial Officer |
PTGX |
Protagonist Therapeutics, Inc |
Jan 2, 2024 |
2 |
$0 |
4 |
Jan 4, 2024 |
Chief Financial Officer |
PTGX |
Protagonist Therapeutics, Inc |
May 31, 2023 |
2 |
-$108K |
4 |
Jun 2, 2023 |
Chief Financial Officer |
PTGX |
Protagonist Therapeutics, Inc |
Apr 18, 2023 |
1 |
-$27.6K |
4 |
Apr 19, 2023 |
Chief Financial Officer |
PTGX |
Protagonist Therapeutics, Inc |
Jan 16, 2023 |
2 |
$0 |
4 |
Jan 18, 2023 |
Chief Financial Officer |
PTGX |
Protagonist Therapeutics, Inc |
Apr 18, 2022 |
2 |
$0 |
4 |
Apr 19, 2022 |
Chief Financial Officer |
PTGX |
Protagonist Therapeutics, Inc |
Apr 18, 2022 |
0 |
$0 |
3 |
Apr 19, 2022 |
Chief Financial Officer |